Novo Integrated Sciences, Inc.
NVOS
$0.065
$0.009316.70%
| 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | 08/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 13.29M | 13.52M | 13.66M | 13.04M | 12.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.29M | 13.52M | 13.66M | 13.04M | 12.57M |
| Cost of Revenue | 7.55M | 8.42M | 8.15M | 7.89M | 7.62M |
| Gross Profit | 5.74M | 5.09M | 5.51M | 5.16M | 4.95M |
| SG&A Expenses | 14.06M | 15.56M | 14.89M | 14.79M | 13.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.61M | 23.99M | 23.04M | 22.67M | 21.13M |
| Operating Income | -8.31M | -10.47M | -9.38M | -9.63M | -8.55M |
| Income Before Tax | -16.13M | -24.34M | -12.09M | -13.99M | -13.27M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.13 | -24.34 | -12.09 | -13.99 | -13.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -38.20K | 16.00K | 9.60K | 34.00K | 54.90K |
| Net Income | -16.17M | -24.33M | -12.08M | -13.96M | -13.21M |
| EBIT | -8.31M | -10.47M | -9.38M | -9.63M | -8.55M |
| EBITDA | -6.05M | -8.19M | -7.08M | -7.34M | -6.25M |
| EPS Basic | -0.91 | -1.38 | -0.75 | -1.18 | -2.06 |
| Normalized Basic EPS | -0.51 | -0.84 | -0.45 | -0.71 | -1.29 |
| EPS Diluted | -0.91 | -1.38 | -0.75 | -1.18 | -2.06 |
| Normalized Diluted EPS | -0.51 | -0.84 | -0.45 | -0.71 | -1.29 |
| Average Basic Shares Outstanding | 72.12M | 67.97M | 63.64M | 53.93M | 40.59M |
| Average Diluted Shares Outstanding | 72.12M | 67.97M | 63.64M | 53.93M | 40.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
